BCS Stock Analysis: Barclays | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 96.295m USD | 12M Return: 41.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 135M
EPS Trend: 87.5%
Qual. Beats: 0
Rev. Trend: 94.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Barclays PLC (NYSE: BCS) is a London-headquartered global financial services company founded in 1690, making it one of the oldest banking institutions in the UK. It operates through five main segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank. The company offers a broad range of services including retail banking (current accounts, savings, mortgages, credit cards, and loans), wholesale and investment banking, wealth and investment management, and securities dealing. As a diversified bank, Barclays generates revenue across both consumer-facing and corporate/institutional lines, and trades on the NYSE as an American Depositary Receipt (ADR), allowing US investors to hold shares in the UK-domiciled company.
- UK net interest margins compress as BoE cuts rates
- Investment Banking revenue rises on FICC and advisory recovery
- US credit card losses climb as borrower delinquencies worsen
| Net Income: 7.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.81 > 1.0 |
| NWC/Revenue: -964.0% < 20% (prev -1.48k%; Δ 518.3% < -1%) |
| CFO/TA -0.00 > 3% & CFO -6.21b > Net Income 7.88b |
| Net Debt (-25.9b) to EBITDA (11.8b): -2.20 < 3 |
| Current Ratio: 0.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (13.5b) vs 12m ago 279.6% < -2% |
| Gross Margin: 27.86% > 18% (prev 92.11%; Δ -64.25% > 0.5%) |
| Asset Turnover: 1.81% > 50% (prev 1.72%; Δ 0.08% > 0%) |
| Interest Coverage Ratio: 0.46 > 6 (EBIT TTM 10.0b / Interest Expense TTM 21.7b) |
| A: -0.17 (Total Current Assets 408b - Total Current Liabilities 698b) / Total Assets 1730b |
| B: 0.03 (Retained Earnings 60.4b / Total Assets 1730b) |
| C: 0.01 (EBIT TTM 10.0b / Avg Total Assets 1665b) |
| D: 0.05 (Book Value of Equity 79.4b / Total Liabilities 1651b) |
| Altman-Z'' = -0.89 = CCC |
As of July 29, 2026, the stock is trading at USD 26.98 with a total of 12,004,233 shares traded. Over the past week, the price has changed by -3.40%, over one month by +0.45%, over three months by +17.30% and over the past year by +41.82%.
Current recommended Stop Loss: 25.90 (which is 4% or 1.6 ATR below the current price).
Barclays has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 29.2 | 8.2% |
Market Cap GBP = 72.1b (96.3b USD * 0.7485 USD.GBP)
P/E Trailing = 12.0
P/E Forward = 10.1112
P/S = 3.5544
P/B = 0.9177
P/EG = 1.6851
Revenue TTM = 30.1b GBP
EBIT TTM = 10.0b GBP
EBITDA TTM = 11.8b GBP
Long Term Debt = 76.7b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 73.1b GBP (from shortTermDebt, last fiscal year)
Debt = 220b GBP (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -25.9b GBP (calculated: Debt 220b - CCE 246b)
Enterprise Value = 46.2b GBP (72.1b + Debt 220b - CCE 246b)
Interest Coverage Ratio = 0.46 (Ebit TTM 10.0b / Interest Expense TTM 21.7b)
EV/FCF = -5.72x (Enterprise Value 46.2b / FCF TTM -8.07b)
FCF Yield = -17.48% (FCF TTM -8.07b / Enterprise Value 46.2b)
FCF Margin = -26.84% (FCF TTM -8.07b / Revenue TTM 30.1b)
Net Margin = 26.20% (Net Income TTM 7.88b / Revenue TTM 30.1b)
Gross Margin = 27.86% ((Revenue TTM 30.1b - Cost of Revenue TTM 21.7b) / Revenue TTM)
Gross Margin QoQ = none% (prev 89.68%)
Tobins Q-Ratio = 0.03 (Enterprise Value 46.2b / Total Assets 1730b)
Interest Expense / Debt = 9.86% (Interest Expense 21.7b / Debt 220b)
Taxrate = 21.13% (2.12b / 10.0b)
NOPAT = 7.92b (EBIT 10.0b * (1 - 21.13%))
Current Ratio = 0.58 (Total Current Assets 408b / Total Current Liabilities 698b)
Debt / Equity = 2.77 (Debt 220b / totalStockholderEquity, last quarter 79.4b)
Debt / EBITDA = -2.20 (Net Debt -25.9b / EBITDA 11.8b)
Debt / FCF = 3.21 (negative FCF - burning cash) (Net Debt -25.9b / FCF TTM -8.07b)
Total Stockholder Equity = 77.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.88b / Total Assets 1730b)
RoE = 10.16% (Net Income TTM 7.88b / Total Stockholder Equity 77.6b)
RoCE = 6.51% (EBIT 10.0b / Capital Employed (Equity 77.6b + L.T.Debt 76.7b))
RoIC = 0.72% (NOPAT 7.92b / Invested Capital 1104b)
WACC = 8.36% (E(72.1b)/V(292b) * Re(10.13%) + D(220b)/V(292b) * Rd(9.86%) * (1-Tc(0.21)))
Discount Rate = 10.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -55.51 | Cagr: -48.23%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 87.48 | EPS CAGR: 17.78% | SUE: -0.02 | # QB: 0
Revenue Correlation: 94.64 | Revenue CAGR: 6.70% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.74 | Chg30d=+2.73% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.82 | Chg30d=-0.17% | Revisions=+0% | GrowthEPS=+17.3% | GrowthRev=+6.8%
EPS next Year (2027-12-31): EPS=3.40 | Chg30d=+0.36% | Revisions=+0% | GrowthEPS=+20.3% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +12% (up=3, down=2)